SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-000391
Filing Date
2020-01-02
Accepted
2020-01-02 17:16:44
Documents
1
Period of Report
2019-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6154
  Complete submission text file 0001209191-20-000391.txt   7550
Mailing Address C/O SPRING BANK PHARMACEUTICALS, INC. STE S-7 MILFORD MA 01757
Business Address
Eichler Kurt M (Reporting) CIK: 0001424591 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37718 | Film No.: 20502365

Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Issuer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations